Narayana Translation Research and Incubation Centre (NTRIC)


  • To evolve as an International Centre of Excellence in Translational Research and Promote Invention, Innovation and Entrepreneurship.


  • To Train, counsel, guide and mentor the students and faculties in performing innovative translational research and setting up of the enterprise.
  • To facilitate the scientific interactions between different Departments of Medicine and its allied faculties to generate novel ideas.
  • To provide infrastructure and state-of-art technology to test the hypothesis that could result in an invention.
  • To encourage innovative collaborative basic research to benefit the community and enabling the industry to produce cost effective equipment and drugs.
  • To be a center of excellence that fosters synergy between the academia and the industry that fuels entrepreneurial spirit and inculcates research bent of mind among students to help them to be self -reliant and contribute to the nation building.
  • To nurture technology and knowledge based ventures through their start-up phase by providing the necessary support and promote entrepreneurship.
  • To help medical researchers to obtain intra- and extra-mural research grants to carry out their research and publish the outcome in high-impact scientific journals and patent their findings.

Narayana Translational Research Centre

NTRC (recognized by DSIR, Govt. of India) – is an advanced center established with a view to be at par with international standards in both pre-clinical and clinical research. The infrastructure of the facility is of world class with a built in area of 16,000 Sq.Ft. which includes – Clinical Research Division, Conference Room, four Biosafety level II clean rooms with laminar air flow type II- A in each room to carry out Stem Cell, Molecular biology and Genetic studies. A central Laboratory exists with state of art instruments such as Real- Time PCR, Ultra High Performance Liquid Chromatography (UHPLC), Flow Cytometer, Inverted Fluorescence Microscope, Nanodrop and Microbiology incubator and Laminar hood. As well equipped with necessary equipment’s including cooling centrifuges, refrigerators and freezers (-20 & -80 deg. C), Gel-documentation system and an IR Camera. Outcome of various research activities carried out in this centre were published in both national and international reputed journals.

NTRC – Clinical Research Division

Bio-safety Level II Clean Room Facility

NTRC – Basic Research Division


A two-storeyed Animal facility was established in 1999 and utilized for experimental research in accordance with the CPCSEA guidelines of the Government of India. It fully air –conditioned and houses lab animals such as rats, mice, rabbits and guinea pigs. It facilitates the following activities – UG and PG pharmacy animal practical experiments; in-house medical and paramedical research; inter-institutional research and industrial research. Animal health and well-being is monitored daily by a veterinarian; and animals were well maintained and fed ad libitum by animal care-takers (24 h x 7 d)


4Ms. A.Mohana RupaResearch Assistance 4Ms. A.Mohana RupaResearch Assistance
Sl. No Name Designation
1 Dr. Srinivasa Rao Associate Professor
2 Dr. K. Babu Rao Veterinarian
3 Ms. Priyanka Research Assistance
4 Ms. A.Mohana Rupa Research Assistance
5 Mr. K. Bhargav Ram Computer Assistant
6 Mr. V. Eswaraiah Lab Assistant
7 Mr. Rahamathulla Kaja Animal Care Staff
8 Mrs. Mabajan B Animal Care Staff
9 Mrs. S.K Bashera Sweeper – Animal House
10 Mrs. Ramanamma Sweeper – Research Lab and Clinical Division


Sl.noName of the InstrumentModel /Make
1Flow CytometerBD FACSCanto ll
2HPLCThermo Scientific Ultimate 3000
3Atomic Absorption SpectroscopyShimadzu
4Inverted fluorescence microscopeOlympus U- LH100HG
5RT-PCRBio-Rad; CFX 96
6Deep Freezers (-20 deg. C &  -80 deg. C )LG & Terumo penpol DF80U 300L;
7 Laminar airflow type II A  and CO2  IncubatorsThermo Fisher
8Gel  Documentation UnitG-Box
9UV SpectrophotometerSystronics
10NanodropThermo Fisher 2000
11Microbiology hood and incubatorHitech; Technico
12Hot air ovenYarko
13Gel DryerThermocon
14Trans-illuminatorLark LIUVT312
15Flame PhotometerSystronics 129
17Muffle FurnaceBTI Biotech
18HumalyzerHuman 300
20Precision balancesSystronics


On going:-

Sl. No Titles Dept Principal Investigator
1 A Randomised Double Blind, Three – Arm, placebo Controlled, Parallel – design, Multi- center, Clinical endpoint Bioequivalence study to ketoconazole shampoo 2% (Test Product) compared with ketoconazole shampoo 2% (Reference Product) in adult subjects with tinea versicolor Dermatology Study Dr. Shabana Shaik
2 Developement, validation and scale-up of point of care, wearable tinnitus care device patch and automated Smartphone app for management of tinnitus ENT Dr V Krishna Chaitanya Professor ENT Narayana Medical College Nellore


Sl.noTitleDeptPrincipal Investigator
1An Academic Multicentre Open Label Single Arm Study to Record the Efficacy of Indomethacin among Confirmed COVID-19 patients with Mild and Moderate SymptomsPulmonologyDr.Prasanna purna
2An Academic Retrospective Study to Record the Efficacy of Paracetamol along With
Other Drugs, Among Confirmed Covid-l9 Patients with Mild and Moderate Symptoms
PulmonologyDr.Prasanna purna
3clinical evaluation for the prophylactic role of traditional Siddha formulation Vishasura Kudineer enlisted
in Advisory of the Ministry of AYUSH for COVID-19
PulmonologyDr. Prasanna purna
4An Academic Study to Evaluate Laphre-A Vaginal Pessary for Treatment of
Bacterial Vaginosis
Obstetrics and GynecologyDr.Neha
5An open-label, Balanced, Randomized, Multicentre, Multi-Dose, Two-Treatment, Parallel, Comparative
phase ilt ClinicalTrialto Determine the safety and Efficacy of Biapenem 300mg lnjections with l-nem (lmipenem 500 mg+ Cilastin 500 mg)injection in lndian Human Adult, Patients with Various Complicated lnfections.
General MedicineDr.Bheemasen soren
6An academic study of the Investigation of Digital Biomarkers for Early Detection
of Surgical Site Infections.
General SurgeryDr.Mahidhar reddy
7A Prospective, Randomized, Active controlled, observer-blind clinical study safety Evaluating the and Hemostat efficacy of Absorbabre Hemostat powder in comparison with AristarM AH (Absorbabre Hemostat) in Mild or Moderate parenchymal or Soft Tissue Bleeding during General Surgery.General SurgeryDr.Mahidhar reddy
8Randomized, Parallel Group, Phase III Study to Compare Safety and Efficacy of
BFLUID with a Commercially Available Solution,IYUTRIFLEX PBRI as a Control product in
Patients undergoing Gastrectomy or Colectomy
Surgical Gastro entomologyDr. Thirunavukkarasu
9A Prospective, Mulu-center, phase IV Study to
Assess the Safety, Efficacy and Immunogenicity of
BIOSULIN@ 30:70 (Insulin Injection, Biphasic Isophane
100 IU/ml) in Treatment
of Patients Diagnosed with Type 2 Diabetes Mellitus
10Phase IV, Multi-Center, Open Lable, Clinical Trial to Assess the Safety and Efficacy of Remdesivir in Moderate to Severe SARS CoV2 Infection (COVID-19) in Indian patients.PulmonologyDr. Prasanna purna || Co-PI : Dr. Ravi Teja
11A Prospective, Open Label, Multicenter, Single Arm Phase Iv Study to Evaluate the Safety and Effectiveness of Avigan® (Favipiravir) Tablets 200 Mg as Add On to Standard Supportive Care in Adult Indian Patients with Mild to Moderate Covid-19 Disease- Project submitted and in evaluation processPulmonologyDr. Chappadi Rajesh Reddy|| Co-PI : Dr. PrasannaPurna
12Randomized, Parallel Group, Phase III Study to Compare Safety and Efficacy of BFLUID with a Commercially Available Solution, NUTRIFLEX PERI, as a Control Product in Patients Undergoing Gastrectomy or ColectomySurgical Gastro entomologyDr. Thirunavukkarasu

Activities conducted :-

Dr. Ishima Badhwar, M.B.B. S, M. Tech, Clinical Consultant Elsevier, Head of Customer engagement division, Elsevier India and South Asia.

Registrants Profile-
Total two hundred and forty-four registrants were from India (95%) and other countries (5%) which includes – Bahrain, Sweden, Japan and Malaysia. Indian registrants were from across the country with higher percentage from Andhra Pradesh (75%), followed by Tamil Nadu (11%), and Telangana (9%); rest of the 2% are from the following states – Maharashtra, Karnataka, New Delhi and Haryana.

Reference Link-Scientific Writing and Searching Medical Databases | Narayana Medical COllege

Dr. Venugopalan Cheriyath & Dr. Izhar A Khan, are Associate Professors from Dept. of Biological Sciences, Texas A&M University-Commerce, Texas, USA.

Registrants Profile-
Total Registrants –494, From India – 96%, Rest of the world 4% – from the following countries – United States of America (USA), Saudi Arabia, Oman, Qatar, Bahrain, Ethiopia, Malaysia and Japan. Distribution of registrants from different states of India is as follows – Andhra Pradesh (30%), Tamil Nadu (17%), Karnataka (14%), Puducherry (7%), Telangana (5%), Kerala (5%), rest 22% are from – Maharashtra, Uttar Pradesh, Punjab, Jharkhand, Rajasthan, Madhya Pradesh, West Bengal, Uttrakhand, Himachal Pradesh, Gujarat, Haryana and Odisha.

Reference Link-International Webinar on PhD Thesis Writing | Narayana Medical College Nellore

I. Dr. Madhavi Dokur, Ph.D, Head of HSE, Shantha Biotechnics Pvt. Limited, (A Sanofi Company), Hyderabad, India.

II. Dr. Richa Arya, Ph.D, Assistant Professor, Cytogenetics Laboratory, Department of Zoology, Banaras Hindu University, Varanasi, India.

Registrants Profile-
Registrants – 548, out of it 532 are from India (97.1%), rest are from the following countries – United States of America (USA), United Kingdom (UK), Germany, Japan and Saudi Arabia. Distribution of registrants from different states of India is as follows – Andhra Pradesh (81%), Tamil Nadu (14%), Karnataka (3%), rest 2% are from – Maharashtra, Telangana, Uttar Pradesh, Punjab, Jharkhand, Rajasthan and Kerala.

Reference Link-minutes of biosafety | Narayana Medical College

Speaker –
Dr. Narasimman Gurusamy, University of Tennessee Health Science Centre (UTHSC), Memphis, Tennessee (TN), USA.

Registrants Profile-
Registrants – 539 out of it 529 are from India (98%), rest are from the following countries – United States of America (USA), Japan and Saudi Arabia. Distribution of registrants from different states of India is as follows – Andhra Pradesh (95%), Tamil Nadu (2%), Kerala (2%), rest are from – Maharashtra, Telangana, Uttar Pradesh, Karnataka and Uttarakhand.

Reference Link-therapeutic applications of human induced pluripotent stem cells

I. Dr. Noohu Abdullah Khan, Assistant Professor, Clinical Pharmacy, King Khalid University, Kingdom of Saudi Arabia.
II. Dr. Ayyub Ali Patel, Assistant Professor, Dept. of Biochemistry, College of Medicine, King Khalid University, Kingdom of Saudi Arabia.

Registrants Profile-
Total Four Hundred and Thirty-two (432) registrants; Indian registrants – 98%, foreign nationals -2% from USA, Oman and Saudi Arabia. Indian registrants are from the following states – Andhra Pradesh (69%), Tamil Nadu (20%), Maharashtra (4%), Karnataka (2%) and rest 2% are from Telangana and Kerala.

Reference Link-international webinar on computerised assessment blended learning in medical education/

  • International Webinar on “PKN1 – Alternative Target in Advanced Prostate Cancer” by V. Balaji Venkadakrishnan, Department of Medical Oncology, Dana-Farber Cancer Institute and Research Fellow at Harvard Medical School, Boston, Massachusetts, USA; on January 7, 2021. Slide 1 (

Seminar on “Micronutrient Deficiencies – Hidden Hunger”, by Dr. Malavika Vinod Kumar, Managing Trustee, Sundar Serendipity Foundation & The Micronutrient Research Foundation, Chennai, Tamil Nadu, India; on January 25, 2021

  • Workshop on – “Idea, Innovation, Incubation & Entrepreneurship”, by Ravi Prasad, Principal, Narayana Engineering College, Gudur, Andhra Pradesh, India; on February 20, 2021. Slide 1 (

National Webinar on “Stress – Paradigm Shift”, by T.S.I. Sakthi Siva Kumar, Sr. Manager, Training & Development, TTK Healthcare Ltd. Chennai, Tamil Nadu, India; on May 8, 2021. (Stress-A-Paradigm-Shift-Webinar-Minutes.pdf (

International Webinar on “Mass Spectrometry-based Proteomics & its Application in Medicine”, by Dr. Srinivasan Yuvaraj, M.Sc., Ph.D. Project Scientist, Institute of Genome Research, Tokushima University, Tokushima, Japan; on 5th July, 2021 ((Intl-Webinar-Proteomics-application-in-Medicine-July-5-2021.pdf (


Institute Innovation Council activity (IIC) – Strategies to Promote Innovation, Invention & Entrepreneurship, by Dr. Sivakumar Vijayaraghavalu, Prof & Head, Narayana Translational Research and Incubation Center; 5th August, 2021. (INSTITUTIONS INNOVATION COUNCIL First Quarterly meeting (

  • National webinar on – “Intellectual Property Rights – Copyrights” by Dr. P. Karthigeyan, M. Tech, Ph.D. (Intellectual Property rights), PGDIPR, DICFS (Cyber Security), PGDEP (Entrepreneurship), PGDCFS (Criminology & forensic Science), R&D Manager, MSME-TC, Ministry of MSME, Government of India. Former Research scientist, I.I.T Madras, GI Advocate No. 57 DPIIT, Ministry of commerce & Industry, Govt. of India, on 6th August, 2021. (IPR-copyrights-workshop-minutes.pdf (


  • IIC activity – A session on “Building an Innovation/Product Fit for Market” by Arun Sethuraman,

(General Management Program, Harvard Business School, USA) Founder and Chief Executive Officer, Crely Healthcare Private Limited, 7 Temasek Blvd, Singapore 038987; on August 19, 2021

  • IIC activity – World Entrepreneur Day Celebration – “Panel Discussion with Staff Entrepreneurs” by Rakesh Manne, Dr. N. Sreenivasan, Dr. Chinni Suneel from Narayana Dental College and Hospital; on August 21, 2021.